Welcome to our dedicated page for SRX Health Solutions news (Ticker: SRXH), a resource for investors and traders seeking the latest updates and insights on SRX Health Solutions stock.
SRx Health Solutions, Inc. (NYSE American: SRXH) issues frequent press releases and SEC-referenced announcements that document its transition toward a digital-asset treasury operating model and its planned acquisition of EMJ Crypto Technologies Inc. (EMJX). The news flow provides insight into how the company is reshaping its strategy around a Gen2 digital-asset treasury platform that uses quantitative models, artificial intelligence and systematic risk controls.
Recent news items describe the definitive agreement to acquire EMJX, stockholder approval for a future name change to EMJX, Inc. and a planned ticker change to EMJX upon closing of the transaction. Company announcements also cover the deployment of an initial allocation of capital into digital assets such as Bitcoin and Ethereum, which the company characterizes as part of a measured, model-driven treasury management approach rather than short-term speculation.
Other SRXH news highlights enhancements to the EMJX platform, including integration of OpenAI large language models for research and risk decision support and the use of prediction-market probability data to strengthen its internal risk-intelligence framework. Governance and capital-markets updates appear regularly, such as the appointment of new directors with experience in cannabis, capital markets and cryptocurrency treasury strategies, amendments to the company’s charter to increase authorized shares, and private placements of preferred stock and warrants.
SRXH news releases also address NYSE American listing matters, including notifications of stockholders’ equity deficiencies and acceptance of the company’s plan to regain compliance with continued listing standards. For investors tracking SRXH, the news feed offers a consolidated view of transaction milestones, treasury activities, platform development and regulatory communications. Monitoring this page helps readers follow how the company’s proposed combination with EMJX progresses and how its digital-asset treasury strategy evolves over time.
SRx Health Solutions (NYSE American: SRXH) has signed a non-binding Letter of Intent to acquire 100% of Royal Uranium's assets, a uranium royalty business with an extensive portfolio across multiple countries. The acquisition includes 18 uranium royalties across exploration and development projects in Canada, Colombia, Argentina, and Namibia.
The strategic move aligns with increasing demand for nuclear energy, particularly driven by AI and data center power requirements. The company plans to rebrand with a new name and ticker symbol to reflect its focus on energy royalties. Key partnerships include major uranium operators like Cameco, UEC, Denison Mines, and ISO Energy. Global data center power consumption is projected to surge 160% by 2030, with AI-related demand expected to add 200 TWh annually.
SRx Health Solutions (NYSE American: SRXH) has announced the cancellation of approximately 18.8 million shares of its capital stock following a Settlement Agreement with former officers of its Canadian subsidiary, SRx Canada. The cancelled shares, which represent about 60% of the total outstanding shares, were originally issued during the acquisition of SRx Canada.
The cancellation is part of a Settlement, Share Forfeiture and Mutual Release Agreement where the Company agrees to release the Forfeiting Stockholders from certain claims. The Company plans to pursue legal action against other former SRx Canada officers who are not part of this Settlement Agreement to recover stockholder value.
SRx Health Solutions (NYSE American: SRXH) announced that its Canadian subsidiary, SRx Canada, has obtained an Initial Order under the Companies' Creditors Arrangement Act (CCAA) from the Ontario Superior Court of Justice. The court granted several key provisions including:
The company secured debtor-in-possession (DIP) financing of up to $1.75 million to support working capital needs and continued operations. A court-appointed monitor, Grant Thornton Limited, will oversee the proceedings and manage a sale process for SRx Canada's assets. The parent company and its U.S. subsidiary are not included in any bankruptcy proceedings.
SRx Health Solutions (NYSE:SRXH) announced that its Canadian subsidiary, SRx Health Solutions Canada, has initiated creditor protection proceedings under the Companies' Creditors Arrangement Act (CCAA). The company will seek a stay of proceedings and debtor-in-possession (DIP) financing to maintain stability while exploring restructuring options.
The decision comes after careful evaluation of SRx Canada's financial situation. The restructuring may include a potential sale of all or part of the Canadian business through a Court-supervised process. Importantly, the company's U.S. operations, including its Halo subsidiary, will not be affected by the CCAA proceedings, and no U.S. bankruptcy filing is expected.
SRx Health Solutions (NYSE American: SRXH) announced key leadership changes effective immediately. The company has appointed its current President, Kent Cunningham, to the position of CEO, while current CEO Adesh Vora will transition to the role of Vice Chairman.
SRx Health Solutions (NYSE American: SRXH) has successfully secured significant financing through two key initiatives. The company completed a $7.3 million convertible note financing led by insiders and existing investors, while also securing a $50 million equity line of credit (ELOC).
The combined funding will strengthen SRXH's balance sheet and provide working capital for growth initiatives. The company plans to use the proceeds to pursue M&A opportunities in the U.S., expand its specialty pharma platform in Canada, and invest in next-generation capabilities to enhance patient access and operational efficiency.
SRx Health Solutions (NYSE: SRXH) has announced a strategic shift in its cryptocurrency portfolio by selling $1.5 million worth of Solana (SOL) tokens and purchasing Ethereum (ETH). The company's Chairman, Adesh Vora, confirmed their commitment to maintaining cryptocurrency investments as part of their treasury strategy, aiming to create long-term value for shareholders through portfolio diversification.
SRx Health Solutions (NYSE: SRXH) has announced an expansion of its treasury strategy through Bitcoin acquisition. This follows the company's recent $1.5 million purchase of Solana (SOL) tokens. The company plans to allocate up to 10% of future cash flows and reserves into cryptocurrencies (Bitcoin and Solana) and precious metals (gold and silver). Additionally, SRXH is considering establishing a dedicated crypto treasury subsidiary or integrating it into their health platform through a potential industry partnership.